TY - JOUR
T1 - Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes
AU - Beeve, Alec T.
AU - Brazill, Jennifer M.
AU - Scheller, Erica L.
N1 - Funding Information:
This work was supported by grants from the NIH including U01-DK116317, R00-DE024178, and T32-AR060719.
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Purpose of Review: The goal of this review is to explore clinical associations between peripheral neuropathy and diabetic bone disease and to discuss how nerve dysfunction may contribute to dysregulation of bone metabolism, reduced bone quality, and fracture risk. Recent Findings: Diabetic neuropathy can decrease peripheral sensation (sensory neuropathy), impair motor coordination (motor neuropathy), and increase postural hypotension (autonomic neuropathy). Together, this can impair overall balance and increase the risk for falls and fractures. In addition, the peripheral nervous system has the potential to regulate bone metabolism directly through the action of local neurotransmitters on bone cells and indirectly through neuroregulation of the skeletal vascular supply. Summary: This review critically evaluates existing evidence for diabetic peripheral neuropathy as a risk factor or direct actor on bone disease. In addition, we address therapeutic and experimental considerations to guide patient care and future research evaluating the emerging relationship between diabetic neuropathy and bone health.
AB - Purpose of Review: The goal of this review is to explore clinical associations between peripheral neuropathy and diabetic bone disease and to discuss how nerve dysfunction may contribute to dysregulation of bone metabolism, reduced bone quality, and fracture risk. Recent Findings: Diabetic neuropathy can decrease peripheral sensation (sensory neuropathy), impair motor coordination (motor neuropathy), and increase postural hypotension (autonomic neuropathy). Together, this can impair overall balance and increase the risk for falls and fractures. In addition, the peripheral nervous system has the potential to regulate bone metabolism directly through the action of local neurotransmitters on bone cells and indirectly through neuroregulation of the skeletal vascular supply. Summary: This review critically evaluates existing evidence for diabetic peripheral neuropathy as a risk factor or direct actor on bone disease. In addition, we address therapeutic and experimental considerations to guide patient care and future research evaluating the emerging relationship between diabetic neuropathy and bone health.
KW - Diabetes
KW - Fracture
KW - Marrow adiposity
KW - Marrow fat
KW - Metabolic bone disease
KW - Microvascular disease
KW - Neuropathy
UR - http://www.scopus.com/inward/record.url?scp=85070751776&partnerID=8YFLogxK
U2 - 10.1007/s11914-019-00528-8
DO - 10.1007/s11914-019-00528-8
M3 - Review article
C2 - 31392667
AN - SCOPUS:85070751776
SN - 1544-1873
VL - 17
SP - 256
EP - 269
JO - Current Osteoporosis Reports
JF - Current Osteoporosis Reports
IS - 5
ER -